1. EZH2-regulated PARP-1 Expression is a Likely Mechanism for the Chemoresistance of Gliomas to Temozolomide
   Qiang Liang et al, 2024, Current Cancer Drug Targets CrossRef
2. Synthesis and Biological Evaluation of Novel 2-imino-4-thiazolidinones as Potential Antitumor Agents for Glioblastoma
   José Coan Campos et al, 2022, Medicinal Chemistry CrossRef
3. A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma
   Beatrice Ferrari et al, 2021, Frontiers in Neuroscience CrossRef
4. MicroRNA Expression Profile Distinguishes Glioblastoma Stem Cells from Differentiated Tumor Cells
   Sara Tomei et al, 2021, Journal of Personalized Medicine CrossRef
5. Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme
   Natália P. Bona et al, 2020, Metabolic Brain Disease CrossRef
6. Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
   Jonas Feldheim et al, 2022, International Journal of Molecular Sciences CrossRef
7. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
   Alja Zottel et al, 2020, International Journal of Molecular Sciences CrossRef
8. P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway
   Jing Lin et al, 2021, Journal of Oncology CrossRef
9. Research progress in protein microarrays: Focussing on cancer research
   Guang Chen et al, 2023, PROTEOMICS – Clinical Applications CrossRef